ICON.LSE Iconic Labs Plc
- Market cap
- GBX 212K
- P/E
- -
- P/B
- 4.68x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is ICON.LSE undervalued?
Graham numberThe Graham number of Iconic Labs Plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Iconic Labs Plc fundamental analysis
No fundamental analysis for Iconic Labs Plc yet.
Iconic Labs Plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Iconic Labs Plc
Iconic Labs Plc does not have significant operations. Previously, it was engaged in the identification and acquisition of companies in the online media, artificial intelligence, and big data gathering, processing, and analysis sectors. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.
Full company profileIconic Labs Plc financial statements
Iconic Labs Plc annual financial statements
| Item | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 25.0K | 50.8K | - | 107K | 509K | 26.8K | 0.00 | 0.00 | 0.00 | - |
| Gross Profit | -1.21M | -2.84M | -278.00 | 107K | 509K | 26.2K | 0.00 | 0.00 | 0.00 | - |
| Operating Income | -1.24M | -2.79M | -219K | -2.49M | -3.10M | -762K | -1.56M | -1.09M | -555K | -476K |
| EBITDA | -1.22M | -2.68M | -218K | -2.83M | -3.10M | -760K | 4.77M | 52.00 | -555K | -476K |
| Net Income | -1.27M | -2.81M | -4.17M | -2.39M | -7.70M | -762K | 4.77M | 419K | -628K | -549K |
| EPS | -281 | -436 | -148 | -9.56 | -3.38 | -0.20 | 1.03 | 0.05 | -0.06 | -0.04 |
| Balance Sheet | ||||||||||
| Total Assets | 1.62M | 1.43M | 38.6K | 361K | 154K | 6.00 | 50.2K | 139K | 95.0K | 21.5K |
| Total Liabilities | 804K | 2.00M | 1.86M | 3.47M | 8.33M | 8.94M | 3.69M | 2.86M | 4.06M | 4.50M |
| Shareholders' Equity | 812K | -569K | -1.82M | -3.11M | -8.18M | -8.94M | -3.64M | -2.72M | -3.96M | -4.48M |
| Cash & Short-term Investments | 1.15M | 615K | 15.6K | 180K | 50.9K | 5.00 | 50.2K | 129K | 35.7K | 4.36K |
| Total Debt | 414K | 1.07M | 79.4K | 1.74M | 2.42M | 2.42M | 1.94M | 2.65M | 3.08M | 3.53M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -700K | -2.14M | -4.08M | -1.60M | 1.15M | -50.9K | -920K | -803K | -448K | -447K |
| Capital Expenditure | 206K | 324K | 7.51K | 39.6K | 3.00 | 0.00 | 0.00 | 3.00 | 448K | 447K |
| Free Cash Flow | -906K | -2.46M | -4.09M | -1.64M | 1.15M | -50.9K | -920K | -803K | -448K | - |
| Ratios | ||||||||||
| ROE | -157.0% | - | - | - | - | - | - | - | - | - |
| ROA | -78.9% | -196.1% | -10,809.1% | -662.6% | -4,996.4% | -12,700,000.0% | 9,491.7% | 300.7% | -661.0% | -2,547.5% |
| Net Profit Margin | -5,099.8% | -5,533.1% | - | -2,227.3% | -1,511.7% | -2,840.8% | - | - | - | - |
| Debt to Equity | 0.51x | - | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Iconic Labs Plc dividends
Iconic Labs Plc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:10000 on Aug 30, 2023.
Who owns Iconic Labs Plc
- Insiders 2.56%
- Institutions 0.11%
- Public & others 97.34%
- Shares outstanding 18.4M
- Free float 13.3M
Iconic Labs Plc company profile
- Company name
- Iconic Labs Plc
- Ticker
- ICON.LSE
- ISIN
- GB00BRBJ3P08
- Exchange
- London Exchange
- Sector
- Communication Services
- Industry
- Media
- Employees
- 3
- Fiscal year end
- June
- Address
- 7 Bell Yard, London, United Kingdom, WC2A 2JR
- Website
- iconiclabs.co.uk
About Iconic Labs Plc
Iconic Labs Plc does not have significant operations. Previously, it was engaged in the identification and acquisition of companies in the online media, artificial intelligence, and big data gathering, processing, and analysis sectors. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.
Iconic Labs Plc management
2- Mr. John Forbes FarquharsonCEO & Director · born 1976
- Dr. Peter HollandsDirector of WideCells Storage and Research Division & Group's Chief Scientific Officer · born 1959